|Bid||3.0800 x 800|
|Ask||3.0800 x 4000|
|Day's Range||2.9400 - 3.1500|
|52 Week Range||2.3900 - 32.1600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
\\- Provides Business Update -TORONTO / ACCESSWIRE / August 7, 2020 / FSD Pharma Inc.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) ("FSD Pharma" or the "Company") announces the closing of a previously announced agreement with investors for the purchase and sale of 2,762,430 Class B Subordinate Voting Shares of the Company ("Shares") and warrants to purchase 1,381,215 Shares (collectively, the "Securities") at a purchase price of US$3.62 per Share in a registered direct offering. Each Share was sold together with one-half of one warrant to purchase a Share. The warrants have an exercise price of US$4.26 per Share, are immediately exercisable and expire five years from the date of issuance.
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please visit:https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-ceo-clip-90sec/FSD Pharma will air on BIZTV throughout the month of August 2020, throughout the day and evenings.FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) fsdpharma.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO ...